iShares Biotechnology ETF · $11.2B$13,634
IBBIBB vsFTXHFTXHFirst Trust Nasdaq Pharmaceuticals ETF · $1.2B$18,039
$10,000 five years ago, dividends reinvested · they hold 36.4% in common
IBBMeasureFTXH
Returns · dividends reinvested
+27.8%Year to dateJan 1 → Nov 3+33.8%
+35.5%1 yearTotal return+46.6%
+24.5%3 years · per year$10,000 became $19,307 · $19,115+24.1%
+6.4%5 years · per year$10,000 became $13,634 · $18,039+12.5%
Cost and income
0.44%Expense ratio$44 · $60 a year on $10k · lower is better0.60%
0.16%Trailing 12-mo yield$16 · $66 a year on $10k0.66%
Risk · past year
−9.6%Worst dropSmaller is better−7.5%
22.7%VolatilityLower is calmer17.7%
IBBFTXH Winner of the row, in its colourEach row: the bigger of the two fills its side
2–6FTXH wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns